Older man sending a text message on his smartphone

(© Prostock-studio - stock.adobe.com)

ANN ARBOR, Mich. — In an age where medical expenses are skyrocketing, a free online tool promises financial relief for prostate cancer patients, potentially saving over $9,000 in drug costs.

“Patients with Medicare Part D have dozens of different drug plans available to choose from, but most patients, unfortunately, are not aware of this. If they compare estimated costs, they could save thousands of dollars each year in drug costs. This could make a huge impact for patients with limited resources,” Dr. Benjamin Pockros from Michigan Medicine explains.

Researchers from the University of Michigan Health Rogel Cancer Center analyzed the out-of-pocket costs for two prescription drugs, Zytiga (abiraterone) and Xtandi (enzalutamide), used in advanced prostate cancer care. They utilized the Medicare Part D Plan Finder to compare costs within 12 different regions across the U.S. with prominent prostate cancer programs.

Out-of-pocket costs for Zytiga ranged from $1,379 to $13,274 across all Part D plans, with an average potential saving of $9,321 in the 12 cities studied. For Xtandi, the cost ranged from $9,854 to $13,061, with a median potential saving of $1,839.

“We know cancer can take a devastating physical, emotional, and financial toll on patients. For those enrolled in Medicare Part D, this plan finder is free and easy to use, and hopefully one small step in improving cancer care in our country,” Dr. Pockros adds in a media release.

The free tool is available at medicare.gov/plan-compare

Prostate cancer pills
Prostate cancer words written on medical blue folder with pills. (© andriano_cz – stock.adobe.com)

The tool’s potential to identify significant savings emphasizes its value for prostate cancer patients, especially when considering the current landscape of medical expenses. By being proactive and using available resources, patients can greatly reduce their out-of-pocket expenses. This becomes increasingly crucial given that fewer than 30 percent of patients report comparing drug plan pricing. The study underscores the necessity of healthcare providers to inform their patients about such tools.

Medicare offers an annual open enrollment period from October to December, where beneficiaries can change plans. With over 49 million Americans enrolled in Medicare Part D and up to 50 different plans to select from, the need for a comprehensive tool like the Medicare Part D Plan Finder becomes indispensable.

This study highlights not just the importance of research but also the practical application of its findings. By merely being aware of the resources available and making informed choices, prostate cancer patients can save thousands on their medication. As the healthcare community strives for better cancer care, integrating such tools and patient awareness is a step in the right direction.

The study is published in The Journal of Urology—Urology Practice.

You might also be interested in: 

About Alexander Olumese, PharmD

Alexander Olumese is a DMV-based registered pharmacist and medical writer. He has over 10 years of experience with community and hospital pharmacies, as well as over 3 years within the pharmaceutical industry as a medical writer within medical affairs. He has a background in a variety of therapeutic areas. However, he specializes in cardiovascular disease, oncology, pain medicine, and infectious disease.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

Chris Melore

Editor

Sophia Naughton

Associate Editor

2 Comments

  1. Rob Reed says:

    I use GoodRx to find lowest drug costs in my area. The discounts are huge. Has worked for 2 years. No affiliation with that web site.

  2. Rob Reed says:

    Zytiga at 250 mg, 120 tablets with Goodrx coupon will cost only $138 bucks at Hannafords in Albany NY. No insurance needed. So hopefully folks will use GoodRx rather than the supposedly “free tool” this article is promoting(obviously for someone’s self interest).